POSC403 Biologic, Biosimilar and Specialty Drug Utilization Trends Among US Employers

Abstract

Authors

RA Brook AA Drnach EW Britt SC Papa IA Beren EM Rosenberg JR Wheeler

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×